13F Filings History of CARNEGIE MELLON UNIVERSITY

Latest 13F report
Q4 2025 - 28 Jan 2026
Value $
$89,297,573
Signature - Title
Charles A. Kennedy - Chief Investment Officer
Location
Pittsburgh, PA
Summary
This page shows a list of all the recent 13F filings made by CARNEGIE MELLON UNIVERSITY. Form 13F is required to be filed within 45 days of the end of a calendar quarter. CARNEGIE MELLON UNIVERSITY reported 5 stock holdings with total value $89,297,573 as of Q4 2025. Top holdings included DUOL, QQQ, IHT, AGPU, and XAGE.

Notify me when CARNEGIE MELLON UNIVERSITY files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 5 $89,297,573 +$46,100 -$9,829 +$36,271 DUOL, QQQ, IHT, AGPU, XAGE 13F-HR 28 Jan 2026, 12:20
Q3 2025 5 $131,560,230 $0 -$137,464 -$137,464 DUOL, QQQ, IHT, POAI, XAGE 13F-HR 13 Nov 2025, 14:00
Q2 2025 5 $154,593,581 +$50,751 -$10,658,208 -$10,607,457 DUOL, QQQ, IHT, XAGE, POAI 13F-HR 07 Aug 2025, 07:21
Q1 2025 6 $129,024,432 +$45,954 -$1,552,700 -$1,506,746 DUOL, QQQ, PDD, INNSUITES HOSPITALITY TR, XAGE 13F-HR 05 May 2025, 10:42
Q4 2024 6 $136,673,490 +$34,533,715 -$9,240,555 +$25,293,160 DUOL, QQQ, PDD, CTCX, IHT 13F-HR 07 Feb 2025, 15:15
Q3 2024 4 $96,901,665 +$12,610 -$2,820,200 -$2,807,590 DUOL, CTCX, IHT, POAI 13F-HR 13 Nov 2024, 11:51
Q2 2024 4 $73,891,675 $0 -$1,756,989 -$1,756,989 DUOL, CTCX, IHT, POAI 13F-HR 08 Aug 2024, 11:38
Q1 2024 6 $80,053,990 $0 -$882,320 -$882,320 DUOL, VERA, CTCX, POAI, NBSE 13F-HR 07 May 2024, 11:25
Q4 2023 6 $82,916,336 +$68,840 -$18,393,143 -$18,324,303 DUOL, CTCX, VERA, NBSE, POAI 13F-HR 02 Feb 2024, 10:56
Q3 2023 7 $78,789,478 +$371,329 -$362,592 +$8,737 DUOL, IEMG, CTCX, VERA, NBSE 13F-HR 01 Nov 2023, 15:05
Q2 2023 6 $71,034,934 $0 -$82,293,923 -$82,293,923 DUOL, IEMG, VERA, NBSE, PREDICTIVE ONCOLOGY INC. 13F-HR 01 Aug 2023, 17:26
Q1 2023 6 $149,623,531 $0 -$75,812,950 -$75,812,950 IEMG, DUOL, NBSE, VERA, PREDICTIVE ONCOLOGY INC. 13F-HR 03 May 2023, 15:25
Q4 2022 6 $182,644,051 +$7,879,691 -$2,371,261 +$5,508,430 IEMG, DUOL, VERA, NBSE, PREDICTIVE ONCOLOGY INC. 13F-HR 07 Feb 2023, 15:38
Q3 2022 6 $179,487,000 $0 -$5,590,986 -$5,590,986 IEMG, DUOL, NBSE, VERA, PREDICTIVE ONCOLOGY INC 13F-HR 10 Nov 2022, 14:42
Q2 2022 6 $198,918,000 +$1,770,181 -$16,001,099 -$14,230,918 IEMG, DUOL, NBSE, VERA, PREDICTIVE ONCOLOGY INC 13F-HR 05 Aug 2022, 12:33
Q1 2022 6 $239,072,000 +$20,057,797 -$9,317,298 +$10,740,499 IEMG, DUOL, NBSE, VERA, PREDICTIVE ONCOLOGY INC 13F-HR 10 May 2022, 12:31
Q4 2021 6 $249,981,000 $0 $0 $0 IEMG, DUOL, NBSE, VERA, PREDICTIVE ONCOLOGY INC 13F-HR 11 Feb 2022, 12:29